| |
| |
|
| Insider
Information: |
Springer Timothy A |
| Relationship: |
Director, 10% Owner |
| City: |
Chestnut Hill |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
11,364,518 |
|
|
Indirect Shares
|
5,323,744 |
|
|
| Direct
Value |
$169,493,879 |
|
|
|
Indirect Value
|
$93,773,595 |
|
|
| Total
Shares |
16,688,262 |
|
|
| Total
Value |
$263,267,473 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
41
|
0
|
|
Stock
price went up :
|
11
|
0
|
| Stock
price went down : |
30
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 1.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Selecta Biosciences Inc |
SELB |
Director, 10% Owner |
2024-04-08 |
4,379,899 |
2024-04-08 |
1,931,123 |
Premium* |
|
|
Scholar Rock Holding Corp |
SRRK |
10% Owner |
2019-12-10 |
2,376,567 |
2019-12-10 |
580,855 |
Premium* |
|
|
Morphic Holding, Inc. |
MORF |
Director, 10% Owner |
2023-06-28 |
4,608,052 |
2023-06-28 |
2,811,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2023-11-15 |
4 |
A |
$403.47 |
$49,999,998 |
D/D |
123,925 |
123,925 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2023-05-03 |
4 |
B |
$45.00 |
$47,250,000 |
I/I |
1,050,000 |
2,768,464 |
2.25 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2023-02-13 |
4 |
A |
$35.35 |
$28,499,983 |
I/I |
806,223 |
1,718,464 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2021-12-09 |
4 |
B |
$3.06 |
$11,468,880 |
I/I |
3,748,000 |
22,902,427 |
2.25 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2021-05-21 |
4 |
B |
$45.50 |
$10,569,423 |
I/I |
232,295 |
707,314 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2023-11-15 |
4 |
A |
$403.47 |
$9,999,999 |
I/I |
24,785 |
24,785 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2016-06-27 |
4 |
B |
$14.00 |
$9,940,000 |
I/I |
710,000 |
1,237,028 |
2.1 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2021-05-21 |
4 |
B |
$3.19 |
$8,847,398 |
I/I |
2,773,479 |
17,254,427 |
2.25 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2021-03-05 |
4 |
B |
$70.00 |
$7,000,000 |
I/I |
100,000 |
475,019 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2019-01-25 |
4 |
B |
$1.50 |
$6,000,000 |
D/D |
4,000,000 |
4,456,597 |
2.39 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2017-06-27 |
4 |
B |
$17.71 |
$5,999,989 |
D/D |
338,791 |
355,413 |
2.39 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2019-12-23 |
4 |
A |
$1.46 |
$5,753,695 |
I/I |
3,940,887 |
5,486,463 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2020-10-22 |
4 |
B |
$2.63 |
$4,656,699 |
I/I |
1,770,204 |
13,486,460 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2021-05-26 |
4 |
B |
$4.00 |
$3,705,699 |
I/I |
926,170 |
19,154,427 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2020-10-06 |
4 |
B |
$1.68 |
$3,365,800 |
I/I |
2,000,000 |
7,486,463 |
2.25 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2021-05-25 |
4 |
B |
$45.83 |
$2,981,381 |
I/I |
65,000 |
812,314 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2019-08-20 |
4 |
A |
$1.81 |
$2,896,000 |
D/D |
1,600,000 |
6,056,597 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2024-03-26 |
4 |
OE |
$1.46 |
$2,876,847 |
I/I |
1,970,443 |
33,043,849 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2020-10-23 |
4 |
B |
$2.71 |
$2,699,737 |
I/I |
994,488 |
14,480,948 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2020-10-21 |
4 |
B |
$2.50 |
$2,199,472 |
I/I |
880,000 |
11,716,256 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2020-10-20 |
4 |
B |
$2.21 |
$2,013,193 |
I/I |
910,000 |
10,836,256 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2021-05-24 |
4 |
B |
$3.38 |
$1,992,076 |
I/I |
590,000 |
17,844,427 |
2.25 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • • |
2019-08-20 |
4 |
A |
$1.81 |
$1,991,000 |
I/I |
1,100,000 |
1,545,576 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2021-08-19 |
4 |
B |
$54.71 |
$1,865,010 |
I/I |
33,000 |
900,621 |
2.25 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2021-05-24 |
4 |
B |
$45.43 |
$1,860,311 |
I/I |
40,000 |
747,314 |
2.25 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
